← Open Payments lookup

RABANY CLAYBORN: Open Payments

NPI 1003163460 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,038 in 42 payments from 14 companies in 2025. Trend: 2023 $221 · 2024 $667 · 2025 $1,038

Food & beverage: $1,038
CompanyPaymentsAmount
ABBVIE INC.10$287
Otsuka America Pharmaceutical, Inc.8$206
Alkermes, Inc.3$85
Vanda Pharmaceuticals Inc.4$77
E.R. Squibb & Sons, L.L.C.3$76
Astellas Pharma US Inc2$55
AstraZeneca Pharmaceuticals LP2$48
Aimmune Therapeutics, Inc.2$44
Lundbeck LLC2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$31

Products named: VRAYLAR, ABILIFY MAINTENA, ARISTADA, FANAPT, COBENFY, Veozah, AIRSUPRA, ZENPEP.

Industry payments across WI — which companies pay providers there.